Renal cell carcinoma: An update for the practicing urologist.
about
Cytoreductive Surgery in the Management of Renal Tumours: Rationale, Current Evidence and Future Perspectives.Low neighbor of Brca1 gene expression predicts poor clinical outcome and resistance of sunitinib in clear cell renal cell carcinoma.Is there a role for adjuvant therapy after surgery in “high risk for recurrence” kidney cancer? An update on current concepts
P2860
Renal cell carcinoma: An update for the practicing urologist.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Renal cell carcinoma: An update for the practicing urologist.
@en
Renal cell carcinoma: An update for the practicing urologist.
@nl
type
label
Renal cell carcinoma: An update for the practicing urologist.
@en
Renal cell carcinoma: An update for the practicing urologist.
@nl
prefLabel
Renal cell carcinoma: An update for the practicing urologist.
@en
Renal cell carcinoma: An update for the practicing urologist.
@nl
P2093
P2860
P1476
Renal cell carcinoma: An update for the practicing urologist.
@en
P2093
Paulo Bergerot
Robert A Figlin
Sumanta K Pal
P2860
P356
10.1016/J.AJUR.2015.04.012
P577
2015-01-01T00:00:00Z